Clindamycin Completed Phase 2 Trials for Skin Rash Treatment ; NCT , Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer.
Serious skin and other reactions can occur with clindamycin. Seek medical treatment if you have symptoms of a drug reaction such as skin rash
Twenty-three days later, a skin rash appeared and clindamycin was ceased, but the skin rash developed into a generalized maculopapular rash accompanied by
Serious skin and other reactions can occur with clindamycin. Seek medical treatment if you have symptoms of a drug reaction such as skin rash
Twenty-three days later, a skin rash appeared and clindamycin was ceased, but the skin rash developed into a generalized maculopapular rash accompanied by
Twenty-three days later, a skin rash appeared and clindamycin was ceased, but the skin rash developed into a generalized maculopapular rash accompanied by
If you develop a serious rash or any of these skin symptoms, clindamycin should be In this event your doctor will discontinue the treatment with clindamycin
Twenty-three days later, a skin rash appeared and clindamycin was ceased, but the skin rash developed into a generalized maculopapular rash accompanied by
Twenty-three days later, a skin rash appeared and clindamycin was ceased, but the skin rash developed into a generalized maculopapular rash accompanied by
-Rainbowrose6